Cure My Disease

Don't miss your cure!

 Log in / Sign up

New drug trial aims to slow multiple sclerosis brain damage

NCT ID NCT06220669

Ongoing Disease control Sponsor: Eli Lilly and Company Source: ClinicalTrials.gov ↗

Summary

This study is testing whether an investigational drug called LY3541860 can safely slow the formation of new brain lesions in adults with relapsing forms of multiple sclerosis. About 63 participants will receive either the drug or a placebo for approximately 9 months, followed by 6 months of monitoring. The main goal is to see if the treatment reduces new areas of inflammation in the brain as seen on MRI scans.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Centre Hospitalier Intercommunal - Site de Poissy

    Poissy, 78303, France

  • Clinirem

    Lublin, 20-064, Poland

  • Conquest Research LLC - Winter Park - ClinEdge - PPDS

    Winter Park, Florida, 32789, United States

  • Consultants in Neurology

    Northbrook, Illinois, 60062, United States

  • ETG Neuroscience - PPDS

    Warsaw, 02-677, Poland

  • Fondazione IRCCS Di Rilievo Nazionale Istituto Nazionale Neurologico Carlo Besta-VIA MANGIAGALLI 3

    Milan, 20133, Italy

  • Hope Neurology

    Knoxville, Tennessee, 37922, United States

  • IBISMED Wielospecjalistyczne Centrum Medyczne

    Zabrze, 41-800, Poland

  • M.A. - LEK A.M. Maciejowscy SC. Centrum Terapii SM

    Katowice, 40-571, Poland

  • NEURO-MEDIC Sp. z o. o.

    Katowice, 40-686, Poland

  • Nemocnica Ruzinov

    Bratislava, 826 06, Slovakia

  • Neurocentrum Bydgoszcz sp. z o.o.

    Bydgoszcz, 85-796, Poland

  • Niepubliczny Zaklad Opieki Zdrowotnej NEURO-KARD Ilkowski i Partnerzy Spolka Partnerska Lekarzy

    Poznan, 61-853, Poland

  • Panhandle Research and Medical Clinic

    Gulf Breeze, Florida, 32561, United States

  • Pauls Stradins Clinical Univeristy Hospital

    Riga, LV-1002, Latvia

  • Premier Neurology

    Greer, South Carolina, 29605, United States

  • ProNeuro Centrum Medyczne

    Żory, 44-240, Poland

  • Queen's Medical Centre

    Nottingham, NG7 2UH, United Kingdom

  • Sharlin Health and Neurology

    Ozark, Missouri, 65721-5315, United States

  • Specjalistyczna Praktyka Lekarska prof. Grzegorz Opala

    Katowice, 40-060, Poland

Conditions

Explore the condition pages connected to this study.

MULTIPLE SCLEROSIS